Charles S. Ryan insider trades

Open-market stock purchases and sales by Charles S. Ryan, President at Quince Therapeutics, Inc, from SEC Form 4 filings since Dec 22, 2014.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +54%.

Recent trades

DateStockTradeValue
Jan 23, 2026QNCX Quince Therapeutics, IncBought (not open market)—

Companies traded

  • QNCX Quince Therapeutics, Inc: 1 buy, last Jan 23, 2026
  • NTRP Neurotrope, Inc: other filings, last Dec 1, 2020
  • APDN Applied DNA Sciences Inc: other filings, last May 17, 2019
  • BRTX BioRestorative Therapies, Inc: 3 buys, last Mar 25, 2019

Get free alerts when Charles S. Ryan files a new trade →